Intas becomes the first and only company in India to offer IVF and gynecology therapies with needle-free injections
The multicenter study will enroll 75 patients across 16 sites in Germany, Bulgaria, Poland, and Spain
Indian Pharmacopoeia is now recognised in 19 countries, reflecting growing international confidence in India’s regulatory and scientific capabilities
Wayrilz represents a new approach to ITP by targeting the disease at its root through multi-immune modulation
BBIL will guarantee production and supply of MTBVAC to more than 70 countries across Africa and Southeast Asia
The move strengthens Sanofi’s presence in adult immunization by combining Dynavax’s innovative vaccines with Sanofi’s global scale and development capabilities
Afrezza comes in single-use cartridges, delivered via a simple inhaler device. Users select the appropriate cartridge, load it, inhale the insulin, and remove the cartridge
The opening of our 1000th pharmacy in Karnataka marks an important step
Subscribe To Our Newsletter & Stay Updated
